A randomized prospective study of prophylactic cloxacillin in breast reduction surgery

Annals of Plastic Surgery

Volumn 74, Issue 1, 2015, Pages 17-21

  Lewin, Richard ^a   Elander, Anna ^a   Thorarinsson, Andri ^a   Kölby, Lars ^a   Sahlin, Per Erik ^a   Lundberg, Jonas ^a   Panczel, Alexander ^a   Lidén, Mattias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Breast reduction surgery; Infection; Prophylactic antibiotics; Prospective; Randomize; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; CLOXACILLIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; BREAST RECONSTRUCTION; CONTROLLED STUDY; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; CLOXACILLIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; MAMMAPLASTY; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84927020435     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0000000000000352     Document Type: Article

References (37)

1. Iwuagwu OC, Walker LG, Stanley PW, et al. Randomized clinical trial examining psychosocial and quality of life benefits of bilateral breast reduction surgery. Br J Surg. 2006;93:291-294.
2. Collins ED, Kerrigan CL, Kim M, et al. The effectiveness of surgical and nonsurgical interventions in relieving the symptoms of macromastia. Plast Reconstr Surg. 2002;109:1556-1566.
3. Saariniemi KM, Joukamaa M, Raitasalo R, et al. Breast reduction alleviates depression and anxiety and restores self-esteem: a prospective randomised clinical trial. Scand J Plast Reconstr Surg Hand Surg. 2009;43:320-324.
4. Blomqvist L, Eriksson A, Brandberg Y. Reduction mammaplasty provides longterm improvement in health status and quality of life. Plast Reconstr Surg. 2000;106:991-997.
5. Blomqvist L, Brandberg Y. Three-year follow-up on clinical symptoms and health-related quality of life after reduction mammaplasty. Plast Reconstr Surg. 2004;114:49-54.
6. Haridas M, Malangoni MA. Predictive factors for surgical site infection in general surgery. Surgery. 2008;144:496-501 discussion 501-493.
7. Woodfield JC, Beshay NM, Pettigrew RA, et al. American Society of Anesthesiologists classification of physical status as a predictor of wound infection. ANZ J Surg. 2007;77:738-741.
8. Kompatscher P, von Planta A, Spicher I, et al. Comparison of the incidence and predicted risk of early surgical site infections after breast reduction. Aesthet Plast Surg. 2003;27:308-314.
9. Tejirian T, Di Fronzo LA, Haigh PI. Antibiotic prophylaxis for preventing wound infection after breast surgery: a systematic review and metaanalysis. J Am Coll Surg. 2006;203:729-734.
10. Sevin A, Senen D, Sevin K, et al. Antibiotic use in abdominoplasty: prospective analysis of 207 cases. J Plast Reconstr Aesthet Surg. 2007;60:379-382.
11. Ahmadi AH, Cohen BE, Shayani P. A prospective study of antibiotic efficacy in preventing infection in reduction mammaplasty. Plast Reconstr Surg. 2005;116:126-131.
12. Lewin R, Goransson M, Elander A, et al. Risk factors for complications after breast reduction surgery. J Plast Surg Hand Surg. 2014;48:10-14.
13. Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg. 1998;85:1232-1241.
14. Zelenitsky SA, Silverman RE, Duckworth H, et al. A prospective, randomized, double-blind study of single high dose versus multiple standard dose gentamicin both in combination with metronidazole for colorectal surgical prophylaxis. J Hosp Infect. 2000;46:135-140.
15. Baran CN, Sensoz O, Ulusoy MG. Prophylactic antibiotics in plastic and reconstructive surgery. Plast Reconstr Surg. 1999;103:1561-1566.
16. Weber WP, Marti WR, Zwahlen M, et al. The timing of surgical antimicrobial prophylaxis. Ann Surg. 2008;247:918-926.
17. Classen DC, Evans RS, Pestotnik SL, et al. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med. 1992;326:281-286.
18. Cosimelli M, Tedesco M, Giannarelli D, et al. The role of the administration time of prophylactic antibiotic therapy in colorectal cancer surgery: a review of 6, 069 patients from 36 randomized clinical trials. Ann Ital Chir. 1993;64:527-532.
19. Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med. 1990;322:153-160.
20. Platt R, Zucker JR, Zaleznik DF, et al. Perioperative antibiotic prophylaxis and wound infection following breast surgery. J Antimicrob Chemother. 1993;31(suppl B):43-48.
21. Serletti JM, Davenport MS, Herrera HR, et al. Efficacy of prophylactic antibiotics in reduction mammoplasty. Ann Plast Surg. 1994;33:476-480.
22. Veiga-Filho J, Veiga DF, Sabino-Neto M, et al. The role of antibiotics in reduction mammaplasty. Ann Plast Surg. 2010;65:144-146.
23. Blomqvist G, Alberius P. Nipple-areola transposition by the superolateral-rotation pedicle technique in reduction mammaplasty: surgical description. Ann Plast Surg. 1990;24:475-480.
24. Saariniemi KM, Keranen UH, Salminen-Peltola PK, et al. Reduction mammaplasty is effective treatment according to two quality of life instruments. A prospective randomised clinical trial. J Plast Reconstr Aesthet Surg. 2008;61:1472-1478.
25. Chadbourne EB, Zhang S, Gordon MJ, et al. Clinical outcomes in reduction mammaplasty: a systematic review and meta-analysis of published studies. Mayo Clin Proc. 2001;76:503-510.
26. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitionsofnosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992;20:271-274.
27. Andenaes K, Amland PF, Lingaas E, et al. A prospective, randomized surveillance study of postoperative wound infections after plastic surgery: a study of incidence and surveillance methods. Plast Reconstr Surg. 1995;96:948-956.
28. Tanner J, Padley W, Kiernan M, et al. A benchmark too far: findings from a national survey of surgical site infection surveillance. J Hosp Infect. 2013;83:87-91.
29. Hall JC, Hall JL. The measurement of wound infection after breast surgery. Breast J. 2004;10:412-415.
30. Bartsich S, Ascherman JA, Whittier S, et al. The breast: a clean-contaminated surgical site. Aesthet Surg J. 2011;31:802-806.
31. Hardwicke JT, Bechar J, Skillman JM. Are systemic antibiotics indicated in aesthetic breast surgery? A systematic review of the literature. Plast Reconstr Surg. 2013;131:1395-1403.
32. Bartlett SP, Burton RC. Effects of prophylactic antibiotics on wound infection after elective colon and rectal surgery: 1960 to 1980. Am J Surg. 1983;145:300-309.
33. Hall JC, Christiansen KJ, Goodman M, et al. Duration of antimicrobial prophylaxis in vascular surgery. Am J Surg. 1998;175:87-90.
34. Worning AM, Frimodt-Moller N, Ostri P, et al. Antibiotic prophylaxis in vascular reconstructive surgery: a double-blind placebo-controlled study. J Antimicrob Chemother. 1986;17:105-113.
35. Gillespie WJ, Walenkamp G. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev. 2001:CD000244.
36. Esposito S, Leone S, Noviello S, et al. Antibiotic prophylaxis in hernia repair and breast surgery: a prospective randomized study comparing piperacillin/tazobactam versus placebo. J Chemother. 2006;18:278-284.
37. Thomas R, Alvino P, Cortino GR, et al. Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: a randomized double-blind trial involving 1, 766 patients. Chemotherapy. 1999;45:217-223.